This quarterly publication will keep you up to date on PRA’s Rare Disease Team focus, achievements, and new initiatives.
We’ve supported more than 150 infectious disease studies, leading to the approval of 13 important marketed products.
Benefits of Cross-Border Enrollment
How Technology is Reshaping the Rare Disease Landscape
This white paper provides practical strategies for easing the participation burden and introduces considerations for selecting technology that can…